196 related articles for article (PubMed ID: 17024247)
1. Role of different pathways of the complement cascade in experimental bullous pemphigoid.
Nelson KC; Zhao M; Schroeder PR; Li N; Wetsel RA; Diaz LA; Liu Z
J Clin Invest; 2006 Nov; 116(11):2892-900. PubMed ID: 17024247
[TBL] [Abstract][Full Text] [Related]
2. Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model.
Li Q; Ujiie H; Shibaki A; Wang G; Moriuchi R; Qiao HJ; Morioka H; Shinkuma S; Natsuga K; Long HA; Nishie W; Shimizu H
J Immunol; 2010 Dec; 185(12):7746-55. PubMed ID: 21076071
[TBL] [Abstract][Full Text] [Related]
3. Macrophages, but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: macrophage-mediated neutrophil infiltration depends on mast cell activation.
Chen R; Fairley JA; Zhao ML; Giudice GJ; Zillikens D; Diaz LA; Liu Z
J Immunol; 2002 Oct; 169(7):3987-92. PubMed ID: 12244200
[TBL] [Abstract][Full Text] [Related]
4. Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid.
Chen R; Ning G; Zhao ML; Fleming MG; Diaz LA; Werb Z; Liu Z
J Clin Invest; 2001 Oct; 108(8):1151-8. PubMed ID: 11602622
[TBL] [Abstract][Full Text] [Related]
5. Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.
Liu Z; Sui W; Zhao M; Li Z; Li N; Thresher R; Giudice GJ; Fairley JA; Sitaru C; Zillikens D; Ning G; Marinkovich MP; Diaz LA
J Autoimmun; 2008 Dec; 31(4):331-8. PubMed ID: 18922680
[TBL] [Abstract][Full Text] [Related]
6. Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid.
Leighty L; Li N; Diaz LA; Liu Z
Arch Dermatol Res; 2007 Nov; 299(9):417-22. PubMed ID: 17879094
[TBL] [Abstract][Full Text] [Related]
7. Immunopathology of bullous pemphigoid, an autoimmune and inflammatory skin blistering disease.
Liu Z
Keio J Med; 2003 Jun; 52(2):128-33. PubMed ID: 12862365
[TBL] [Abstract][Full Text] [Related]
8. Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.
Ujiie H; Sasaoka T; Izumi K; Nishie W; Shinkuma S; Natsuga K; Nakamura H; Shibaki A; Shimizu H
J Immunol; 2014 Nov; 193(9):4415-28. PubMed ID: 25261486
[TBL] [Abstract][Full Text] [Related]
9. The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury.
Fang H; Zhang Y; Li N; Wang G; Liu Z
Front Immunol; 2018; 9():407. PubMed ID: 29545809
[TBL] [Abstract][Full Text] [Related]
10. The role of complement in experimental bullous pemphigoid.
Liu Z; Giudice GJ; Swartz SJ; Fairley JA; Till GO; Troy JL; Diaz LA
J Clin Invest; 1995 Apr; 95(4):1539-44. PubMed ID: 7706459
[TBL] [Abstract][Full Text] [Related]
11. Role of FcRs in animal model of autoimmune bullous pemphigoid.
Zhao M; Trimbeger ME; Li N; Diaz LA; Shapiro SD; Liu Z
J Immunol; 2006 Sep; 177(5):3398-405. PubMed ID: 16920981
[TBL] [Abstract][Full Text] [Related]
12. Differential roles for beta2 integrins in experimental autoimmune bullous pemphigoid.
Liu Z; Zhao M; Li N; Diaz LA; Mayadas TN
Blood; 2006 Feb; 107(3):1063-9. PubMed ID: 16234355
[TBL] [Abstract][Full Text] [Related]
13. A major role for neutrophils in experimental bullous pemphigoid.
Liu Z; Giudice GJ; Zhou X; Swartz SJ; Troy JL; Fairley JA; Till GO; Diaz LA
J Clin Invest; 1997 Sep; 100(5):1256-63. PubMed ID: 9276744
[TBL] [Abstract][Full Text] [Related]
14. Bullous pemphigoid: using animal models to study the immunopathology.
Liu Z
J Investig Dermatol Symp Proc; 2004 Jan; 9(1):41-6. PubMed ID: 14870984
[TBL] [Abstract][Full Text] [Related]
15. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid.
Liu Z; Shipley JM; Vu TH; Zhou X; Diaz LA; Werb Z; Senior RM
J Exp Med; 1998 Aug; 188(3):475-82. PubMed ID: 9687525
[TBL] [Abstract][Full Text] [Related]
16. The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid.
Heimbach L; Li Z; Berkowitz P; Zhao M; Li N; Rubenstein DS; Diaz LA; Liu Z
J Biol Chem; 2011 Apr; 286(17):15003-9. PubMed ID: 21393236
[TBL] [Abstract][Full Text] [Related]
17. The pathophysiology of bullous pemphigoid.
Kasperkiewicz M; Zillikens D
Clin Rev Allergy Immunol; 2007 Oct; 33(1-2):67-77. PubMed ID: 18094948
[TBL] [Abstract][Full Text] [Related]
18. Dual targets for mouse mast cell protease-4 in mediating tissue damage in experimental bullous pemphigoid.
Lin L; Bankaitis E; Heimbach L; Li N; Abrink M; Pejler G; An L; Diaz LA; Werb Z; Liu Z
J Biol Chem; 2011 Oct; 286(43):37358-67. PubMed ID: 21880713
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
20. Bullous pemphigoid: role of complement and mechanisms for blister formation within the lamina lucida.
Iwata H; Kitajima Y
Exp Dermatol; 2013 Jun; 22(6):381-5. PubMed ID: 23651418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
